{"id":12375,"date":"2020-08-05T15:55:22","date_gmt":"2020-08-05T15:55:22","guid":{"rendered":"https:\/\/bengalnewstimes.com\/?p=12375"},"modified":"2020-08-05T15:55:22","modified_gmt":"2020-08-05T15:55:22","slug":"lupin-introduced-anti-covid-19-drug-at-%e2%82%b949-a-tablet","status":"publish","type":"post","link":"https:\/\/bengalnewstimes.com\/?p=12375","title":{"rendered":"Lupin introduced anti-COVID-19 drug at \u20b949 a tablet"},"content":{"rendered":"<p><\/p>\n<div id=\"content-body-14269002-32278882\">\n<p>Lupin Ltd. has announced the introduction of its Favipiravir version in India under the brand name Covihalt for treatment of mild to moderate COVID-19. <\/p>\n<p>Lupin\u2019s Covihalt dosage strength has been developed keeping in mind convenience of administration, the company said. <\/p>\n<p>It is available as 200 mg tablets in the form of a strip of 10 tablets, and priced at \u20b949 per tablet. <\/p>\n<p>While Sun Pharma\u2019s FluGuard is priced at \u20b935 a tablet Glenmark\u2019s FabuFlu is priced at \u20b975 a tablet.<\/p>\n<p>Rajeev Sibal, president, India Region Formulations (IRF), Lupin said, \u201cIn these tough times, it is our duty to support the nation in fighting this pandemic and ensuring affordable drugs are made available for impacted patients.\u201d<\/p>\n<p>\u201cWe believe that we can leverage our expertise in managing widespread community diseases like TB to proactively reach patients across India and ensure access to Covihalt through our strong distribution network and field force,\u201d he added.<\/p>\n<\/div>\n<div style=\"display:none\">\n<div class=\"col-xs-12 col-md-12 col-lg-12 col-sm-12\">\n<div class=\"subscriptioncontainer\">\n<div class=\"subscriptioncontainermain\">\n<div class=\"col-xs-12 col-sm-12 col-md-12 subscripeleftcontent\">\n<p class=\"planTodayDiv text-center\">You have reached your limit for free articles this month.<\/p>\n<p class=\"planTodayDiv text-center\"> To get full access, please subscribe. <\/p>\n<p class=\"signinlnk text-center\" data-category=\"Meterpaywall\" data-label=\"sign\"> Already have an account ? <a href=\"https:\/\/subscription.thehindu.com\/signup?utm_source=meterpaywall&amp;utm_medium=32278882&amp;utm_campaign=business\" class=\"signintodayspaper\">Sign in<\/a>\n<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p>Show Less Plan <i class=\"fa fa-angle-down\"\/><\/p>\n<\/div>\n<div class=\"subscriptionbenefits\">\n<h4 class=\"subscriptionbenefitstitle\">Subscription Benefits Include<\/h4>\n<div class=\"col-xs-12\">\n<div class=\"col-xs-12 col-sm-6 col-md-6 nopad\">\n<div class=\"reasonforsubscrptionitems\">\n<span class=\"reasonforsubscrptionitemsimg todayimg\"\/><\/p>\n<div class=\"reasonforsubscrptionitemscontent\">\n<h6 class=\"reasonforsubscrptionitemscontenttitle\">Today&#8217;s Paper<\/h6>\n<p class=\"reasonforsubscrptionitemscontentlead\">Find mobile-friendly version of articles from the day&#8217;s newspaper in one easy-to-read list.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"col-xs-12 col-sm-6 col-md-6 nopad\">\n<div class=\"reasonforsubscrptionitems\">\n<span class=\"reasonforsubscrptionitemsimg fasterimg\"\/><\/p>\n<div class=\"reasonforsubscrptionitemscontent\">\n<h6 class=\"reasonforsubscrptionitemscontenttitle\">Faster pages<\/h6>\n<p class=\"reasonforsubscrptionitemscontentlead\">Move smoothly between articles as our pages load instantly.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"col-xs-12 col-sm-6 col-md-6 nopad\">\n<div class=\"reasonforsubscrptionitems\">\n<span class=\"reasonforsubscrptionitemsimg adimg\"\/><\/p>\n<div class=\"reasonforsubscrptionitemscontent\">\n<h6 class=\"reasonforsubscrptionitemscontenttitle\">Unlimited Access<\/h6>\n<p class=\"reasonforsubscrptionitemscontentlead\">Enjoy reading as many articles as you wish without any limitations.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"col-xs-12 col-sm-6 col-md-6 nopad\">\n<div class=\"reasonforsubscrptionitems\">\n<span class=\"reasonforsubscrptionitemsimg dashimg\"\/><\/p>\n<div class=\"reasonforsubscrptionitemscontent\">\n<h6 class=\"reasonforsubscrptionitemscontenttitle\">Dashboard<\/h6>\n<p class=\"reasonforsubscrptionitemscontentlead\">A one-stop-shop for seeing the latest updates, and managing your preferences.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"col-xs-12 col-sm-6 col-md-6 nopad\">\n<div class=\"reasonforsubscrptionitems\">\n<span class=\"reasonforsubscrptionitemsimg recomimg\"\/><\/p>\n<div class=\"reasonforsubscrptionitemscontent\">\n<h6 class=\"reasonforsubscrptionitemscontenttitle\">Personalised recommendations<\/h6>\n<p class=\"reasonforsubscrptionitemscontentlead\">A select list of articles that match your interests and tastes.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"col-xs-12 col-sm-6 col-md-6 nopad\">\n<div class=\"reasonforsubscrptionitems\">\n<span class=\"reasonforsubscrptionitemsimg briefimg\"\/><\/p>\n<div class=\"reasonforsubscrptionitemscontent\">\n<h6 class=\"reasonforsubscrptionitemscontenttitle\">Briefing<\/h6>\n<p class=\"reasonforsubscrptionitemscontentlead\">We brief you on the latest and most important developments, three times a day.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"subscriptiontext col-xs-12\">\n<p>\n*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.\n<\/p>\n<\/div>\n<\/div>\n<div>\n<div class=\"tlreaderBack\" style=\"display:none;\">\n<h3>A letter from the Editor<\/h3>\n<hr\/>\n<p>Dear subscriber,<\/p>\n<p>Thank you!<\/p>\n<p>Your support for our journalism is invaluable. It\u2019s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.<\/p>\n<p>The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.<\/p>\n<p>We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.<\/p>\n<p>Suresh Nambath<\/p>\n<\/div>\n<\/div>\n<p><a href=\\\"https:\/\/www.thehindu.com\/business\/lupin-introduced-anti-covid-19-drug-at-49-a-tablet\/article32278882.ece\\\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lupin Ltd. has announced the introduction of its Favipiravir version in India under the brand name Covihalt for treatment of mild to moderate COVID-19. Lupin\u2019s Covihalt dosage strength has been developed keeping in mind convenience of administration, the company said. It is available as 200 mg tablets in the form [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":383,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","footnotes":""},"categories":[36],"tags":[],"class_list":["post-12375","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-banking-business"],"jetpack_featured_media_url":"https:\/\/bengalnewstimes.com\/wp-content\/uploads\/2020\/06\/og-image.jpg","_links":{"self":[{"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/posts\/12375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12375"}],"version-history":[{"count":0,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/posts\/12375\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=\/wp\/v2\/media\/383"}],"wp:attachment":[{"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bengalnewstimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}